NTRK2 and Dyskinesia: Interestingly, TrkB cell surface reduction did not affect TrkB phosphorylation levels after long-term treatment with a DRD2 agonist, which might explain why previous studies have reported that high doses of levodopa that induced dyskinesia rescue spine morphology in iSPNs.